Matheus Braga

Dr. Matheus Braga

Análises clínicas e Biomedicina, Universidade Estadual de Maringá, Maringá, Paraná, Brazil
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
MBMatheus Braga
Matheus Braga
FLFernanda Formaggi Lara-Armi
Fernanda Formaggi Lara-Armi
JNJanisleya Silva Ferreira Neves
Janisleya Silva Ferreira Neves
MRMarco Antônio Rocha-Loures
Marco Antônio Rocha-Loures
MTMariana de Souza Terron-Monich
Mariana de Souza Terron-Monich
Jeane Eliete Laguila VisentainerJeane Eliete Laguila Visentainer
Jeane Eliete Laguila Visentainer
Ankylosing spondylitis (AS) is a chronic autoimmune inflammatory disease that mainly affects the axial and sacroiliac joints. Single-nucleotide polymorphisms (SNPs) in genes encoding cytokines have been associated with AS, which can interfere with the production of these cytokines and contribute to the development of AS. In order to contribute to a better understanding of the pathology of AS, our objective was to investigate a possible association of the IL10 −1082 A>G SNP (rs1800896) with AS and to evaluate the serum levels of TNF-α, IL-10, IL-17A, and IL-17F in AS patients and controls comparing them with their respective genotypes (TNF rs1800629, IL10 rs1800896, IL17A rs2275913, and IL17F rs763780). Patients and controls were selected from the Maringá University Hospital and the Maringá Rheumatism Clinic, in Paraná State, Southern Brazil, and they were diagnosed by the ASAS Criteria. In total, 149 patients and 169 controls were genotyped for the IL10 −1082 A>G polymorphism using a polymerase chain reaction with sequence specific primers (PCR-SSP); the measurement of TNF-α serum levels was performed through the immunofluorimetric test and IL-10, IL-17A, and IL-17F using an ELISA test. There was a high frequency of the IL10 −1082 G allele in AS patients compared with controls with an odds ratio of 1.83 and 95% confidence interval of 1.32 to 2.54, and a significant difference in the genotype frequencies of the IL10 −1082 A/G+G/G between patients and healthy controls, with an odds ratio of 3.01 and 95% confidence interval of 1.75 to 5.17. In addition, increased serum levels of IL-10 were observed in AS patients: 2.38 (IQR, 0.91) pg/ml compared with controls 1.72 (IQR 0.93) pg/ml (P = 0.01). Our results also showed an association between IL17F rs763780 C/T+T/T genotypes and increased serum levels of IL-17F in patients with AS and also in controls. We can conclude that patients with the A/G and G/G genotypes for −1082 A>G (rs1800896) in the IL10 gene are three times more likely to develop AS, that the serum level of IL-10 was higher in AS patients and that the IL17F rs763780 polymorphism can affect the levels of IL-17F in the serum of patients and controls in the same way.

2 June 2024 in Expert Review of Molecular Diagnostics
Verified
Journal Article
Closed access
MBMatheus Braga
Matheus Braga
MSMariana Akemi Sonoda Shiga
Mariana Akemi Sonoda Shiga
PSPedro Emanuel Santiago Silva
Pedro Emanuel Santiago Silva
AYAléia Harumi Uchibaba Yamanaka
Aléia Harumi Uchibaba Yamanaka
VSVictor Hugo Souza
Victor Hugo Souza
JVJeane Eliete Laguila Visentainer
Jeane Eliete Laguila Visentainer
A distinct phenotype in Coronavirus disease 2019 (Covid-19) was observed in severe patients, consisting of a highly impaired interferon (IFN) type I response, an exacerbated inflammatory response. The aim of the present study was to investigate a possible association of single nucleotide polymorphisms (SNPs), in five genes relation to the immune response, rs3775291 in TLR3; rs2292151 in TICAM1; rs1758566 in IFNA1; rs1800629 in TNF, and rs1800795 in IL6 with the severity of Covid-19. A cross-sectional study was performed, with non-severe and severe/critical patients diagnosed with Covid-19, by two public hospitals in Brazil. In total, 300 patients were genotyped for the SNPs, 150 with the non-severe form of the disease and 150 with severe/critical form. The T/T genotype of TLR3 in recessive model show 58% of protection against severe/critical Covid-19; as well as the genotypes G/A+A/A of TICAM1 in dominant model with 60% of protection, and in a codominant model G/A with 57% and A/A with 71% of protection against severe/critical Covid-19. Comparing severe and critical cases, The T/C genotype of IFNA1 in the codominant model and TC+C/C in the dominant model, showed twice the risk of critical Covid-19. We can conclude that rs3775291, rs2292151 and rs1758566 can influence the Covid-19 severity.

Verified
Journal Article
Open access
PDF file
SGSergio Grava
Sergio Grava
MBMatheus Braga
Matheus Braga
VSVictor Souza
Victor Souza
APAfonso Carrasco Pepineli
Afonso Carrasco Pepineli
AYAléia Harumi Uchibaba Yamanaka
Aléia Harumi Uchibaba Yamanaka
Jeane Eliete Laguila VisentainerJeane Eliete Laguila Visentainer
Jeane Eliete Laguila Visentainer
The high variability of human leukocyte antigen (HLA) genes results in each molecule having distinct antigenic peptide binding capacities, potentially influencing the immune response to SARS-CoV-2. This study aimed to investigate associations between HLA class I (A, B) and class II (DRB1) polymorphisms and COVID-19 severity in a South Brazilian population, and to evaluate the binding affinity of alleles to viral peptides. A cross-sectional study included 503 unvaccinated patients with RT-qPCR-confirmed COVID-19: 145 non-severe, 129 severe, and 229 critical. HLA typing was performed using PCR-SSO and Luminex™ technology. The DRB1*11 allelic group was significantly associated with protection against severe and critical cases, while DRB1*15 was associated with increased risk; both remained significant after Bonferroni correction. Other allelic groups were associated with disease outcomes but lost significance after correction: B*49 and B*08 (risk); and B*37, B*50, and A*03 (protection). In silico analysis revealed that the DRB1*15 allele group showed a higher proportion of strong binders, mostly from non-structural proteins, while DRB1*11:01 binders, though fewer in number, were concentrated in the M protein. These results suggest functional differences in antigen presentation and reinforce the relevance of class II HLA, particularly DRB1, in modulating COVID-19 severity.

17 July 2025 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
Jeane Eliete Laguila VisentainerJeane Eliete Laguila Visentainer
Jeane Eliete Laguila Visentainer
LVLorena Visentainer
Lorena Visentainer
TCThalita Machado Carlesso
Thalita Machado Carlesso
LBLarissa Danielle Bahls-Pinto
Larissa Danielle Bahls-Pinto
MBMatheus Braga
Matheus Braga

13 October 2026 in Expert Review of Molecular Diagnostics
Verified
Journal Article
Closed access
GBGiovana Paola Zaccarias Bemvides
Giovana Paola Zaccarias Bemvides
RSRaquel Rodrigues dos Santos
Raquel Rodrigues dos Santos
MRMilena Eloisa Ribeiro
Milena Eloisa Ribeiro
MBMatheus Braga
Matheus Braga
DCDaniel Caligari
Daniel Caligari
Jeane Eliete Laguila VisentainerJeane Eliete Laguila Visentainer
Jeane Eliete Laguila Visentainer
1. Patients with hematological disorders and cancers are often treated with allogeneic hematopoietic stem cell transplantation (HSCT), sometimes the only chance for a cure [1]. Over time, molecular...

9 May 2023 in Arquivos do Mudi
Verified
Journal Article
Open access
PDF file
MBMatheus Braga
Matheus Braga
PSPedro E. Santiago Silva
Pedro E. Santiago Silva
AYAléia H. U. Yamanaka
Aléia H. U. Yamanaka
VSVictor H. Souza
Victor H. Souza
SGSergio Grava
Sergio Grava
JVJeane Jeane Eliete Laguila Visentainer
Jeane Jeane Eliete Laguila Visentainer
Clinical outcomes of Covid-19 have shown variability between individuals and populations. TICAM1 gene encodes the TRIFF protein, essential in the antiviral response, then the purpose of the study was to assess the effect of the polymorphism (rs2292151) G>A of TICAM1 gene on the severity of COVID-19 in individuals from the northern region of Paraná. A case-control study was performed, including patients, 100 mild and 50 moderate/severe Covid-19 cases, classified according to the WHO, by Hospital Paraná, Maringá, Brazil. The exclusion criteria used were: patients with heart disease, liver disease, other respiratory diseases, HIV, and cancer. The (rs2292151) G>A polymorphism was genotyped by qPCR and statistical analysis was performed using logistic regression in the SNPStats software. The genotype distribution was according to the expected in the Hardy-Weinberg equilibrium. There was an association between the A/A genotype in a codominant model with protection against the severity of the disease (OR=0.14, 95% CI 0.03.-0.75, P = 0.01). The frequency of genotype A/A was 12% in mild cases and 4% in serious cases; the G/A was 44% in mild cases and 30% in serious cases, and the G/G was 44% in mild cases and 66% in serious cases. We can conclude that the A/A genotype (in a codominant genetic model) of the polymorphism (rs2292151) G>A was associated with a protection factor for moderate/severe Covid-19 in this population, however, the genotype determination should be done in a high number of patients.